The emerging questionable benefit of sorafenib as a neo-adjuvant in HCC patients treated with Y-90 radioembolization pending liver transplantation

被引：1
|
作者：
Shouval, Daniel [1 ]
机构：
[1] Hadassah Hebrew Univ Hosp, Liver Unit, Jerusalem, Israel
来源：
JOURNAL OF HEPATOLOGY | 2014年 / 61卷 / 02期
关键词：
HEPATOCELLULAR-CARCINOMA; CHEMOEMBOLIZATION; BRIDGE;
D O I：
10.1016/j.jhep.2014.05.012
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：190 / 192
页数：3
相关论文
共 43 条
  • [1] Neo-Adjuvant Use of Sorafenib for Hepatocellular Carcinoma Awaiting Liver Transplantation
    Minoux, Kate
    Lassailly, Guillaume
    Ningarhari, Massih
    Lubret, Henri
    El Amrani, Medhi
    Canva, Valerie
    Truant, Stephanie
    Mathurin, Philippe
    Louvet, Alexandre
    Lebuffe, Gilles
    Goria, Odile
    Nguyen-Khac, Eric
    Boleslawski, Emmanuel
    Dharancy, Sebastien
    [J]. TRANSPLANT INTERNATIONAL, 2022, 35
  • [2] Impact of neo-adjuvant Sorafenib treatment on liver transplantation in HCC patients - a prospective, randomized, double-blind, phase III trial
    Hoffmann, Katrin
    Ganten, Tom
    Gotthardtp, Daniel
    Radeleff, Boris
    Settmacher, Utz
    Kollmar, Otto
    Nadalin, Silvio
    Karapanagiotou-Schenkel, Irini
    von Kalle, Christof
    Jaeger, Dirk
    Buechler, Markus W.
    Schemmer, Peter
    [J]. BMC CANCER, 2015, 15
  • [3] Impact of neo-adjuvant Sorafenib treatment on liver transplantation in HCC patients - a prospective, randomized, double-blind, phase III trial
    Katrin Hoffmann
    Tom Ganten
    Daniel Gotthardtp
    Boris Radeleff
    Utz Settmacher
    Otto Kollmar
    Silvio Nadalin
    Irini Karapanagiotou-Schenkel
    Christof von Kalle
    Dirk Jäger
    Markus W Büchler
    Peter Schemmer
    [J]. BMC Cancer, 15
  • [4] Prediction of liver hypertrophy in patients undergoing Y-90 radioembolization treatment
    Hou, Xinchi
    Hadjivassiliou, Anastasia
    Klyuzhin, Ivan
    Benard, Francois
    Liu, David
    Rahmim, Arman
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2022, 63
  • [5] Factors impacting survival in colorectal liver metastases treated with Y-90 radioembolization.
    Villa Palacios, J.
    Trivino-Ibanez, E.
    Ciampi-Dopazo, J.
    Gonzalez-Flores, E.
    Rodriguez-Fernandez, A.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S661 - S661
  • [6] ALBI score is useful in selecting liver transplant and Y-90 for HCC patients
    Tan, Chun Han Nigel
    Yeo, Zachery
    Bonney, Glenn
    Ganpathi, Iyer Shridhar
    Madhavan, Krishnakumar
    Kow, Wei Chieh Alfred
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2018, 33 : 413 - 413
  • [7] Patterns of Targeted Hepatic Injury in Patients with Hepatocellular Carcinoma Treated with Ablative Y-90 Radioembolization
    Lewis, Jason
    Toskich, Beau
    Nakhleh, Raouf
    Montazeri, Seyed Ali
    De la Garza-Ramos, Cynthia
    Krishna, Murli
    [J]. MODERN PATHOLOGY, 2022, 35 (SUPPL 2) : 1128 - 1129
  • [8] Patterns of Targeted Hepatic Injury in Patients with Hepatocellular Carcinoma Treated with Ablative Y-90 Radioembolization
    Lewis, Jason
    Toskich, Beau
    Nakhleh, Raouf
    Montazeri, Seyed Ali
    De la Garza-Ramos, Cynthia
    Krishna, Murli
    [J]. LABORATORY INVESTIGATION, 2022, 102 (SUPPL 1) : 1128 - 1129
  • [9] Feasibility of gemcitabine plus cisplatin as neo-adjuvant in cholangiocarcinoma patients prior to liver transplantation
    Esmail, A.
    Xu, J.
    Umoru, G.
    Al-Rawi, H.
    Saharia, A.
    Abdelrahim, M.
    [J]. ANNALS OF ONCOLOGY, 2022, 33 : S310 - S310
  • [10] PROGNOSTIC FACTORS AMONG PATIENTS WITH HEPATOCELLULAR CARCINOMA (HCC) TREATED BY Y90-RADIOEMBOLIZATION (Y90-RE)
    Inarrairaegui, M.
    D'Avola, D.
    Rodriguez, M.
    Bilbao, J. I.
    Martinez-Cuesta, A.
    Alegre, F.
    Herrero, I.
    Quiroga, J.
    Prieto, J.
    Sangro, B.
    [J]. JOURNAL OF HEPATOLOGY, 2009, 50 : S291 - S291
12345